These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

327 related articles for article (PubMed ID: 29486761)

  • 21. Lung fibrosis-associated soluble mediators and bronchoalveolar lavage from idiopathic pulmonary fibrosis patients promote the expression of fibrogenic factors in subepithelial lung myofibroblasts.
    Bouros E; Filidou E; Arvanitidis K; Mikroulis D; Steiropoulos P; Bamias G; Bouros D; Kolios G
    Pulm Pharmacol Ther; 2017 Oct; 46():78-87. PubMed ID: 28865842
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influence of radiological emphysema on lung function test in idiopathic pulmonary fibrosis.
    Bodlet A; Maury G; Jamart J; Dahlqvist C
    Respir Med; 2013 Nov; 107(11):1781-8. PubMed ID: 24051272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The lower airways microbiome and antimicrobial peptides in idiopathic pulmonary fibrosis differ from chronic obstructive pulmonary disease.
    Knudsen KS; Lehmann S; Nielsen R; Tangedal S; Haaland I; Hiemstra PS; Eagan TM
    PLoS One; 2022; 17(1):e0262082. PubMed ID: 34990493
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Risk factors for acute exacerbation of idiopathic pulmonary fibrosis: A systematic review and meta-analysis.
    Qiu M; Chen Y; Ye Q
    Clin Respir J; 2018 Mar; 12(3):1084-1092. PubMed ID: 28332341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Impact of angiopoietin-1 and -2 on clinical course of idiopathic pulmonary fibrosis.
    Uehara M; Enomoto N; Mikamo M; Oyama Y; Kono M; Fujisawa T; Inui N; Nakamura Y; Suda T
    Respir Med; 2016 May; 114():18-26. PubMed ID: 27109807
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hemosiderin-laden macrophages are an independent factor correlated with pulmonary vascular resistance in idiopathic pulmonary fibrosis: a case control study.
    Fukihara J; Taniguchi H; Ando M; Kondoh Y; Kimura T; Kataoka K; Furukawa T; Johkoh T; Fukuoka J; Sakamoto K; Hasegawa Y
    BMC Pulm Med; 2017 Feb; 17(1):30. PubMed ID: 28166761
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Disease progression in idiopathic pulmonary fibrosis with mild physiological impairment: analysis from the Australian IPF registry.
    Jo HE; Glaspole I; Moodley Y; Chapman S; Ellis S; Goh N; Hopkins P; Keir G; Mahar A; Cooper W; Reynolds P; Haydn Walters E; Zappala C; Grainge C; Allan H; Macansh S; Corte TJ
    BMC Pulm Med; 2018 Jan; 18(1):19. PubMed ID: 29370786
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Idiopathic Interstitial Pneumonia Associated With Autoantibodies: A Large Case Series Followed Over 1 Year.
    Collins BF; Spiekerman CF; Shaw MA; Ho LA; Hayes J; Spada CA; Stamato CM; Raghu G
    Chest; 2017 Jul; 152(1):103-112. PubMed ID: 28300570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis.
    Huang Y; Ma SF; Espindola MS; Vij R; Oldham JM; Huffnagle GB; Erb-Downward JR; Flaherty KR; Moore BB; White ES; Zhou T; Li J; Lussier YA; Han MK; Kaminski N; Garcia JGN; Hogaboam CM; Martinez FJ; Noth I;
    Am J Respir Crit Care Med; 2017 Jul; 196(2):208-219. PubMed ID: 28157391
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Gene correlation network analysis to identify regulatory factors in idiopathic pulmonary fibrosis.
    McDonough JE; Kaminski N; Thienpont B; Hogg JC; Vanaudenaerde BM; Wuyts WA
    Thorax; 2019 Feb; 74(2):132-140. PubMed ID: 30366970
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Microbiome in lung explants of idiopathic pulmonary fibrosis: a case-control study in patients with end-stage fibrosis.
    Kitsios GD; Rojas M; Kass DJ; Fitch A; Sembrat JC; Qin S; Veraldi KL; Gibson KF; Lindell K; Pilewski JM; Methe B; Li K; McDyer J; McVerry BJ; Morris A
    Thorax; 2018 May; 73(5):481-484. PubMed ID: 28802277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical characteristics in patients with asymmetric idiopathic pulmonary fibrosis.
    Callahan SJ; Xia M; Murray S; Flaherty KR
    Respir Med; 2016 Oct; 119():96-101. PubMed ID: 27692155
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Idiopathic pulmonary fibrosis prognostic factors - analysis of the Czech registry].
    Doubková M; Uher M; Bartoš V; Šterclová M; Lacina L; Lošťáková V; Binková I; Plačková M; Žurková M; Bittenglová R; Pšikalová J; Šišková L; Lisá P; Petřík F; Polák J; Řihák V; Skřičková J; Vašáková M
    Cas Lek Cesk; 2016; 155(4):22-8. PubMed ID: 27481198
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A comparison of clinical features between patients with idiopathic pulmonary fibrosis combined with emphysema and without emphysema].
    Ma JW; Li ZH; Xu H; Wang HJ; Kang J; Yu RJ
    Zhonghua Jie He He Hu Xi Za Zhi; 2013 Mar; 36(3):173-6. PubMed ID: 23856138
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Correlation of pulmonary function and usual interstitial pneumonia computed tomography patterns in idiopathic pulmonary fibrosis.
    Arcadu A; Byrne SC; Pirina P; Hartman TE; Bartholmai BJ; Moua T
    Respir Med; 2017 Aug; 129():152-157. PubMed ID: 28732823
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Establishment of the mouse model of acute exacerbation of idiopathic pulmonary fibrosis.
    Wei YR; Qiu H; Wu Q; Du YK; Yin ZF; Chen SS; Jin YP; Zhao MM; Wang C; Weng D; Li HP
    Exp Lung Res; 2016; 42(2):75-86. PubMed ID: 27070485
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of the Lung's Microbiome in the Pathogenesis and Progression of Idiopathic Pulmonary Fibrosis.
    Spagnolo P; Molyneaux PL; Bernardinello N; Cocconcelli E; Biondini D; Fracasso F; Tiné M; Saetta M; Maher TM; Balestro E
    Int J Mol Sci; 2019 Nov; 20(22):. PubMed ID: 31717661
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The serum KL-6 levels in untreated idiopathic pulmonary fibrosis can naturally decline in association with disease progression.
    Ishii H; Kushima H; Kinoshita Y; Fujita M; Watanabe K
    Clin Respir J; 2018 Sep; 12(9):2411-2418. PubMed ID: 30015394
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antacid Therapy and Disease Progression in Patients with Idiopathic Pulmonary Fibrosis Who Received Pirfenidone.
    Kreuter M; Spagnolo P; Wuyts W; Renzoni E; Koschel D; Bonella F; Maher TM; Kolb M; Weycker D; Kirchgässler KU; Costabel U
    Respiration; 2017; 93(6):415-423. PubMed ID: 28399537
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Serum metalloproteinases 1 and 7 in the diagnosis of idiopathic pulmonary fibrosis and other interstitial pneumonias.
    Morais A; Beltrão M; Sokhatska O; Costa D; Melo N; Mota P; Marques A; Delgado L
    Respir Med; 2015 Aug; 109(8):1063-8. PubMed ID: 26174192
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.